Regulation of B-Raf Kinase Activity by Tuberin and Rheb Is Mammalian Target of Rapamycin (mTOR)-independent
Open Access
- 1 July 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (29), 29930-29937
- https://doi.org/10.1074/jbc.m402591200
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- TSC2 regulates VEGF through mTOR-dependent and -independent pathwaysCancer Cell, 2003
- Rheb promotes cell growth as a component of the insulin/TOR signalling networkNature, 2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature, 2003
- Rheb is an essential regulator of S6K in controlling cell growth in DrosophilaNature, 2003
- Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migrationOncogene, 2002
- Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cellsOncogene, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- ERK signalling and oncogene transformation are not impaired in cells lacking A-RafOncogene, 2002
- Endothelial apoptosis in Braf-deficient miceNature Genetics, 1997
- Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITYPublished by Elsevier BV ,1995